Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis

N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adjuvants, Immunologic / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Brain / pathology
  • Diagnosis, Differential
  • Humans
  • Interferon-beta / adverse effects*
  • Leukoencephalopathy, Progressive Multifocal / chemically induced
  • Leukoencephalopathy, Progressive Multifocal / pathology*
  • Magnetic Resonance Imaging
  • Multiple Sclerosis, Relapsing-Remitting / pathology*
  • Natalizumab

Substances

  • Adjuvants, Immunologic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Interferon-beta